Genomic Profiling of Non-Small Cell Lung Cancer with Rare Aberrations in EGFR Codon L858 and the Survival Outcome under Real-World First-Line EGFR Tyrosine Kinase Inhibitor Treatment Compared to Classic EGFRL858R.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined